Dr. Rowan T. Chlebowski appears in the following:
Friday, April 15, 2011
The hormones estrogen and progestin have been prescribed to women to relieve symptoms of menopause. Studies have shown that hormone replacement therapy can increase the risk of cancer, but earlier this month, a new study showed that among some women, it can reduce the risk of breast cancer and heart attack. The conflicting information has left many women confused. Dr. Andrea LaCroix, Professor of Epidemiology, Fred Hutchinson Cancer Research Center in Seattle, and Dr. Rowan T. Chlebowski, Professor and Chief, Harbor/UCLA Medical Center, Department of Internal Medicine, Medical Oncology/Hematology, talk about the safety and effectiveness of hormone replacement therapy and try to clarify some of the confusion.